ArticleCancer medicine2023

Growth in eligibility criteria content and failure to accrue among National Cancer Institute (NCI)-affiliated clinical trials.

John S Peterson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.